Purpose: Low testosterone (T) in Klinefelter’s syndrome (KS) can contribute to typical features of the syndrome such as reduced bone mineral density, obesity, metabolic disturbances and increased cardiovascular risk. The aim of the present study is to review and meta-analyze all available information regarding possible differences in metabolic and bone homeostasis profile between T treated (TRT) or untreated KS and age-matched controls. Methods: We conducted a random effect meta-analysis considering all the available data from observational or randomized controlled studies comparing TRT-treated and untreated KS and age-matched controls. Data were derived from an extensive MEDLINE, Embase, and Cochrane search. Results: Out of 799 retrieved articles, 21 observational and 22 interventional studies were included in the study. Retrieved trials included 1144 KS subjects and 1284 healthy controls. Not-treated KS patients showed worse metabolic profiles (including higher fasting glycemia and HOMA index as well as reduced HDL-cholesterol and higher LDL-cholesterol) and body composition (higher body mass index and waist circumference) and reduced bone mineral density (BMD) when compared to age-matched controls. TRT in hypogonadal KS subjects was able to improve body composition and BMD at spinal levels but it was ineffective in ameliorating lipid and glycemic profile. Accordingly, TRT-treated KS subjects still present worse metabolic parameters when compared to age-matched controls. Conclusion: TRT outcomes observed in KS regarding BMD, body composition and glyco-metabolic control, are similar to those observed in male with hypogonadism not related to KS. Moreover, body composition and BMD are better in treated than untreated hypogonadal KS. Larger and longer randomized placebo-controlled trials are advisable to better confirm the present data, mainly derived from observational studies.

Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis / Pizzocaro, A.; Vena, W.; Condorelli, R.; Radicioni, A.; Rastrelli, G.; Pasquali, D.; Selice, R.; Ferlin, A.; Foresta, C.; Jannini, E. A.; Maggi, M.; Lenzi, A.; Pivonello, R.; Isidori, A. M.; Garolla, A.; Francavilla, S.; Corona, G.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 0391-4097. - 43:12(2020), pp. 1675-1687. [10.1007/s40618-020-01299-1]

Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis

Radicioni A.;Foresta C.;Lenzi A.;Pivonello R.;Isidori A. M.;Garolla A.;Francavilla S.;
2020

Abstract

Purpose: Low testosterone (T) in Klinefelter’s syndrome (KS) can contribute to typical features of the syndrome such as reduced bone mineral density, obesity, metabolic disturbances and increased cardiovascular risk. The aim of the present study is to review and meta-analyze all available information regarding possible differences in metabolic and bone homeostasis profile between T treated (TRT) or untreated KS and age-matched controls. Methods: We conducted a random effect meta-analysis considering all the available data from observational or randomized controlled studies comparing TRT-treated and untreated KS and age-matched controls. Data were derived from an extensive MEDLINE, Embase, and Cochrane search. Results: Out of 799 retrieved articles, 21 observational and 22 interventional studies were included in the study. Retrieved trials included 1144 KS subjects and 1284 healthy controls. Not-treated KS patients showed worse metabolic profiles (including higher fasting glycemia and HOMA index as well as reduced HDL-cholesterol and higher LDL-cholesterol) and body composition (higher body mass index and waist circumference) and reduced bone mineral density (BMD) when compared to age-matched controls. TRT in hypogonadal KS subjects was able to improve body composition and BMD at spinal levels but it was ineffective in ameliorating lipid and glycemic profile. Accordingly, TRT-treated KS subjects still present worse metabolic parameters when compared to age-matched controls. Conclusion: TRT outcomes observed in KS regarding BMD, body composition and glyco-metabolic control, are similar to those observed in male with hypogonadism not related to KS. Moreover, body composition and BMD are better in treated than untreated hypogonadal KS. Larger and longer randomized placebo-controlled trials are advisable to better confirm the present data, mainly derived from observational studies.
2020
body composition; bone mineral density; klinefelter’s syndrome; testosterone
01 Pubblicazione su rivista::01a Articolo in rivista
Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis / Pizzocaro, A.; Vena, W.; Condorelli, R.; Radicioni, A.; Rastrelli, G.; Pasquali, D.; Selice, R.; Ferlin, A.; Foresta, C.; Jannini, E. A.; Maggi, M.; Lenzi, A.; Pivonello, R.; Isidori, A. M.; Garolla, A.; Francavilla, S.; Corona, G.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 0391-4097. - 43:12(2020), pp. 1675-1687. [10.1007/s40618-020-01299-1]
File allegati a questo prodotto
File Dimensione Formato  
Pizzocaro_Testosterone_2020.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 690.49 kB
Formato Adobe PDF
690.49 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1557250
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 39
social impact